glp 1 and medicare GLP-1 Drug Coverage Clinical Capsules: Navigating the Medicare

The relationship between GLP-1 therapy and joint pain relief appears to be multifactorial rather than a direct pharmacological effect on joint tissues

Obesity is considered a chronic condition and GLP-1 medications are intended for long-term use Evidence shows that stopping the medication often leads to weight regain Many patients remain on therapy indefinitely, similar to treatments for other chronic conditions (e.g., hypertension or diabetes), provided the medication is effective and well tolerated Periodic reassessment ensures the treatment remains appropriate and beneficial GLP-1 Agonists: A Powerful Tool for Sustainable Weight Management One of the most exciting advancements Ive seen in clinical practice is the use of GLP-1 receptor agonists medications that are transforming how we approach obesity and metabolic health

References Sharma, S., Sankhyan, N., Gulati, S

doi:10.1007/s40520-017-0770-3

This doesnt mean slow progress is necessarily easy